99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than131I;99mTc reduziert nach intrazellulärer Aufnahme in NIS-positiven Zellen in vitro das klonogene Überleben stärker als 131I

NuklearMedizin

Volumn 49, Issue 4, 2010, Pages 154-160

  Wendisch, M ^a   Freudenberg, R ^a   Drechsel, J ^a   Runge, R ^a   Wunderlich, G ^a   Kotzerke, J ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

131I; 99mTc; Auger electrons; Colony forming assay; PC Cl3

Indexed keywords

IODINE 131; PERCHLORATE; PERTECHNETIC ACID TC 99M; SODIUM IODIDE I 131; SODIUM IODIDE SYMPORTER; TECHNETIUM 99M; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; SODIUM IODIDE;

ARTICLE; AUGER ELECTRON SPECTROSCOPY; CELL LINE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; DOSIMETRY; IN VITRO STUDY; RADIOACTIVITY; THYROID CELL; CYTOLOGY; DRUG EFFECT; GAMMA RADIATION; HUMAN; METABOLISM; RADIATION EXPOSURE; RADIATION RESPONSE; THYROID GLAND; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HUMANS; IODINE RADIOISOTOPES; SODIUM IODIDE; SODIUM PERTECHNETATE TC 99M; THYROID GLAND;

EID: 77957007710     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0300     Document Type: Article

References (30)

1. Agostinelli S, Allison J, Amako K et al. GEANT4-a simulation toolkit. Nuclear Instruments & Methods in Physics Research Section a-Accelerators Spectrometers Detectors and Associated Equipment 2003; 506: 250-303.
2. Allison J, Amako K, Apostolakis J et al. Geant4 developments and applications. Ieee Transactions on Nuclear Science 2006; 53: 270-278.
3. Andreeff M, Sommer D, Freudenberg R et al. BeO-OSL detectors for dose measurements in cell cultures. Nuklearmedizin 2009; 48: 227-232.
4. Barone MV, Sepe L, Melillo RM et al. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Oncogene 2001; 20: 6973-6982. (Pubitemid 33052190)
5. Bockisch A, Grünwald F, Kotzerke J. Radionuclides - reasons and teaching. Nuklearmedizin 2009; 48: 55-57.
6. Carlin S, Cunningham SH, Boyd M et al. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models. Cancer Gene Ther 2000; 7: 1529-1536. (Pubitemid 32098764)
7. Feinendegen LE, Neumann RD. Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers. Int J Radiat Biol 2004; 80: 813-822.
8. Freudenberg R, Andreeff M, Oehme L, Kotzerke J. Dosimetry of cell-monolayers in multiwell plates. Nuklearmedizin 2009; 48: 120-126.
9. Goddu SM, Howell RW, Bouchet LG et al. MIRD Cellular S Values. Reston: Society of Nuclear Medicine 1997.
10. Haberkorn U, Henze M, Altmann A et al. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001; 42: 317-325. (Pubitemid 32150524)
11. +. Bioconjug Chem 2005; 16: 582-587.
12. Howell RW. Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1992; 19: 1371-1383.
13. Howell RW. Auger processes in the 21st century. Int J Radiat Biol 2008;84:959-975.
14. Kassis AI. Therapeutic radionuclides: biophysical and radiobiologic principles. Semin Nucl Med 2008; 38: 358-366.
15. Kriehuber R, Kadenbach K, Schultz F, Weiss DG. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter 99mTc. Int J Radiat Biol 2004; 80: 875-880. (Pubitemid 40138149)
16. Leoni SG, Galante PA, Ricarte-Filho JC, Kimura ET. Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3. Genomics 2008; 91: 356-366.
17. 99mTc. Radiat Res 1983; 94: 263-279.
18. 99mTc radiopharmaceuticals. Med Phys 1994; 21: 1921-1926.
19. Oehme L, Dorr W, Wust P, Kotzerke J. Influence of time-dose-relationships in therapeutic nuclear medicine applications on biological effectiveness of irradiation: consequences for dosimetry. Nuklearmedizin 2008; 47: 205-209.
20. 99mTc-radiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis. Mutat Res 2000; 465: 139-144.
21. 125I-iododeoxyuridine. Nuklearmedizin 2009; 48: 233-242.
22. Petrich T, Knapp WH, Potter E. Functional activity of human sodium/iodide symporter in tumor cell lines. Nuklearmedizin 2003; 42: 15-18. (Pubitemid 36231686)
23. 99mTc. Radiat Prot Dosimetry 2006; 122: 80-81.
24. Pouget JP, Santoro L, Raymond L et al. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res 2008; 170: 192-200.
25. 188Re. Nuklearmedizin 2009; 48: 221-226.
26. 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. Eur J Nucl Med Mol Imaging 2007; 34: 638-650.
27. Silva CR, Valsa JO, Caldeira-de-araujo A et al. Evaluation of the cytotoxic and mutagenic potentiality of technetium-99m in Escherichi coli. Cell Mol Biol (Noisy-le-grand) 2002; 48: 783-787.
28. Silva CR, Valsa JO, Canine MS et al. Evaluation of technetium-99m decay on Escherichia coli inactivation: effects of physical or chemical agents. Yale J Biol Med 1998; 71: 7-14.
29. Van Sande J, Massart C, Beauwens R et al. Anion selectivity by the sodium iodide symporter. Endocrinology 2003; 144: 247-252. (Pubitemid 36076113)
30. Wendisch M, Drechsel J, Freudenberg R et al. Cellular damage in vitro. Nuklearmedizin 2009; 48: 208-214.